CACCIOLA, Emma
 Distribuzione geografica
Continente #
NA - Nord America 8.796
EU - Europa 4.346
AS - Asia 3.533
SA - Sud America 642
AF - Africa 121
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 17.455
Nazione #
US - Stati Uniti d'America 8.320
SG - Singapore 1.954
IE - Irlanda 1.342
CN - Cina 1.284
UA - Ucraina 1.268
IT - Italia 676
BR - Brasile 594
CA - Canada 449
RU - Federazione Russa 351
DE - Germania 181
SE - Svezia 122
GB - Regno Unito 87
IN - India 67
FR - Francia 59
CH - Svizzera 55
CI - Costa d'Avorio 49
NL - Olanda 44
VN - Vietnam 35
UZ - Uzbekistan 34
KR - Corea 33
FI - Finlandia 31
PL - Polonia 21
TR - Turchia 21
GR - Grecia 18
CZ - Repubblica Ceca 17
AT - Austria 16
BD - Bangladesh 16
NG - Nigeria 16
AR - Argentina 15
LB - Libano 15
MX - Messico 15
SN - Senegal 14
BE - Belgio 13
RO - Romania 13
TW - Taiwan 12
EC - Ecuador 10
ZA - Sudafrica 10
BG - Bulgaria 9
EG - Egitto 9
JP - Giappone 9
MA - Marocco 9
EU - Europa 8
IQ - Iraq 7
PK - Pakistan 7
VE - Venezuela 7
AU - Australia 6
CO - Colombia 6
IR - Iran 6
ES - Italia 5
JO - Giordania 5
LY - Libia 5
PT - Portogallo 5
DZ - Algeria 4
HK - Hong Kong 4
PE - Perù 4
IL - Israele 3
KE - Kenya 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PY - Paraguay 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
JM - Giamaica 2
KG - Kirghizistan 2
MK - Macedonia 2
NP - Nepal 2
OM - Oman 2
RS - Serbia 2
TN - Tunisia 2
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HU - Ungheria 1
IM - Isola di Man 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
SI - Slovenia 1
SV - El Salvador 1
Totale 17.455
Città #
Dublin 1.338
Jacksonville 1.239
Santa Clara 1.162
Singapore 1.142
Chandler 970
Ashburn 615
Boardman 535
Nanjing 430
Andover 372
Cambridge 365
Lawrence 358
Toronto 353
San Mateo 233
Des Moines 204
Chicago 178
Wilmington 144
Catania 139
Nanchang 123
Hebei 99
Shenyang 96
Saint Petersburg 85
Ottawa 78
Grafing 77
Jiaxing 75
Civitanova Marche 73
Hefei 73
Beijing 71
Changsha 71
Tianjin 68
Abidjan 49
Los Angeles 42
São Paulo 40
Moscow 34
Seoul 33
Dong Ket 30
Bremen 28
Seattle 27
Norwalk 26
Milan 25
Washington 25
Munich 24
Rio de Janeiro 24
Kunming 23
Den Haag 22
Pune 22
Palermo 20
Hangzhou 19
Liberty Lake 19
Ann Arbor 18
Abuja 16
Belo Horizonte 16
Council Bluffs 16
Helsinki 16
Houston 15
Jinan 15
New York 15
Dakar 14
Ningbo 14
San Francisco 14
The Dalles 14
Augusta 13
Brussels 13
Kochi 13
Phoenix 13
Tashkent 12
Florence 11
Hanover 11
Redwood City 11
Rome 11
Brasília 10
Columbus 10
Curitiba 10
Amsterdam 9
Frankfurt Am Main 9
Istanbul 9
Lanzhou 9
Leawood 9
Mumbai 9
Porto Alegre 9
Princeton 9
Taipei 9
Warsaw 9
Zhengzhou 9
Boston 8
Brooklyn 8
Dearborn 8
Edinburgh 8
Taizhou 8
Quito 7
Sofia 7
Stockholm 7
Trento 7
Turku 7
Wokingham 7
Dhaka 6
Fairfield 6
Genoa 6
Lappeenranta 6
Naples 6
Sant'Agata di Militello 6
Totale 11.836
Nome #
Elevated fibronectin plasma levels in diabetes mellitus are expression of increased synthesis and release by vascular endothe- lium. 428
B-linfociti CALLA (CD10) positivi nella leucemia linfatica cronica. 144
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 101
Surgical drain after open or laparoscopic splenectomy: is it needed or contraindicated? 96
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 87
Activation of coaugulation and fibrinolysis in laparoscopic surgery 85
Acute myeloid leukemia occurring in a patient with polycythemia vera in treatment with hydroxyurea 82
Il timing ottimale dell'introito di aspirina nella trombocitemia essenziale 82
Laparoscopic cholecystectomy in adult patients with sicklecell disease. 78
Alterations in ornithine decarboxylase and transglutaminase activities in lymphocytes from untrated patients with chronic lymphocytic leukemia. 78
A rare case of myeloid sarcoma presenting as anal fissure. 78
D-dimer in the diagnostic work up of suspected pulmonary embolism: additional clinical value of PTP 77
Activation coagulation and fibrinolysis in laparoscopic surgery 76
Acute COPD exacerbations cause alteration of the endothelium-coagulative system 75
Preoperative Predictive Factors of Conversions in Laparoscopic Splenectomies 75
Activation of contact phase of blood coagulation can be induced by the sclerosing agent polidocanol: Possible additional mechanism of adverse reaction during sclerotherapy 75
Phase II randomized clinical trial comparing ropeginterferon versus phlebotomy in low-risk patients with polycythemia vera. Results of the pre-planned interim analysis. 75
Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction - Expression of acute phase reaction or index of va- scular endothelium damage? 74
Abnormal Erytropoietin serum levels in acute leukemia could have a role in the pathophysiology of disease. 74
Hemocoagulative post-operative changes after laparoscopic surgery compared to open surgery: the role of lupus anticoagulant 74
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 74
Activated factor XII and thrombin activable fibrynolysis inhibitor levels in essential thrombocythemia and polycythemia vera 73
A cause for conversion of laparoscopic splenectomy: splenic candidiasis 73
Late results after splenectomy in adult idiopathic thrombocytopenic purpura. 71
Laparoscopic cholecystectomuy in adult patients with sickle cell disease 71
Abnormalities of haemostatic balance in essential thrombocythemia and polycythemia vera 71
Laparoscopic splenectomy in patients under the age of eighteen. Experience in 18 cases. 70
All-trans retinoic (ATRA) induced apoptosis in pe- ripheral freshly isolated chronic myeloid leukemia cells. 70
The use of surgical drains in laparoscopic splenectomies. Consideration on a large series of 117 consecutive cases 70
I disordini dell'emostasi nelle emopatie maligne. 69
Adverse outcome in non severe COVID-19: potential diagnostic coagulation tests 69
In vitro sensitivity of B-CLL cells to Fludarabine and Interferons 68
betaFibrinigen G-455-A gene polymorphism: is it a factor for aspirin platelet insensitivity in patients with essential thrombocythemia? 68
Laparoscopic splenectomy: a single center experience 67
Activation of coagulation anf fibrinolysis in laparoscopic surgery 67
Laparoscopic surgery: A randomised controlled trial comparing intraoperative hemodynamic parameters and arterial-blood gas changes at two different pneumoperitoneal pressure values 66
Low dose of ARA-C in chronic myeloid leukemia in blastic transformation 66
How to prevent intraoperative risks and complications in laparoscopic splenectomy 66
A good response rate to recombinant erythropoietin alone may be expected in selected myelodysplastic patients. A preliminary clinical study 66
Idiopathic intramural hematoma of the right colon. A case report and review of the literature. 66
All-trans retinoic acid might also induce apoptosis in freshly isolated chro- nic myeloid leukemia cells 65
The antiphospholipid syndrome in pregnancy: a review article 65
Abnormal production of interleukin (IL)-6 in essential thrombocythemia. 65
Is it Still Reasonable to Raise Doubts on Laparoscopic Splenectomy? 65
Elevated plasma thrombopoietin levels and thrombosis in essential thrombocythemia: a preliminary report 64
Persistent generalized lymphadenopathy (transfusion-related) in an HIV - seropositive heterosexual man with sckle-cell beta-tha- lassemia. 64
Effects of anagrelide on platelet factor 4 and vascular endothelial growth factor levels in patients with essentiial thrombocythemia: a preliminary report 64
Le anemie carenziali. 63
Polidocanol may directly activate the contact phase of blood coagulation during sclerotherapy 63
ECLAP Cooperative Group. A Randomized Trial. 63
Platelet factor 4, vascular endothelial growth factor and prothrombin fragment 1+2 levels in essential thrombocythemia treated with anagrelide 63
Interleukin-8 levels in patients with essential thrombocythemia. 63
Alteration of endothelium-coagulative system during COPD exacerbations 63
Evidence for an aincreased fatty acid utilization in platelets in diabetes mellitus: its correlation withn platelet hyperfunction 63
Il mitoxantrone in polichemioterapia associato allo schema CVP nel trat- tamento dei linfomi non hodgkin. 63
Unusual onset of severe varicella in adult immunocompromised patients 62
Splenic candidiasis : are perispelnic adhesions contraindications for laparoscopic splenectomy? 62
Study on the Anagrelide on Platelet Factor 4 and Vascular Endothelial Growth Factor Levels in Patients with Essential Thrombocythemia 62
Immunomodulating treatment in patients with aplastic anemia. 61
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neolpasms 61
. Trombospondin plasma levels in beta tha- lassemia:sickle cell disease 61
Laparoscopic Splenectomy Reduces the Need for Platelet Transfusion in Patients With Idiopathic Thrombocytopenic Purpura 61
Sopravvivenza libera da trombosi in 734 pazienti con trombocitemia essenziale (WHO 2016) stratificati secondo lo score "Revised International Prognostic Score for Thrombosis in Essential Thrombocythemia (R-IPSET-Th)". Studio del Regostro ItalianoTrombocitemie (RIT) 61
VLA-4 and VLA-5 integrin expression in adult acute lymphoblastic leukemia. 60
Thymostimulin in aplastic anaemia. 60
Essential thrombocythemia and fibroblast growth factor-2: role of anagrelide 60
Trattamento preoperatorio con interleuchina-2 nel carcinoma colorettale. 59
Surgical management of hereditary spherocytosis Current strategies 59
Acquired antithrombin III deficency in sickle cell disease/beta plus thalas- semia. 59
B1-Integrin expression in adult acute lymphoblastic leukemia: Possible relationship with the stem cell antigen CD34 58
Cutaneous vasculitis in non Hodgkin's Lymphoma. 58
Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis 58
Thymostimulin in aplastic anaemia and idiopathic thrombocytopenia. 58
Long-term results after splenectomy in adult idiopathic thrombocitopenic purpura: comparison between open and laparoscopic procedures 58
Angiogenesis in essential thrombocythemia: fibroblast growth factor-2 and vascular endothelial growth factor cross-talk 58
Aspirin-platelet sensotivity in patients with essentila thtombocythemia: role of betafibrinogen G-455-A gene polymorphism 58
Laparoscopic surgery in sickle cell disease 58
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 57
Factor-VIII-rela- ted antigen and vasculitis. 57
Alpha interferon as a first line therapy for angioimmunoblastic lympho- adenopathy. Possible value of DR+ cells in monitoring therapeutical re- sponse. 57
Modification of coaugulation and fibrinolysic parameters in laparoscopic cholecystectomy 57
Role of FcR+ T-cells on the mechanism of the depressed polyclonal immunoglobulin synthesis in human mye- loma. 57
Extra-haematological adverse events in 1075 essential thrombocythemia patients treated with hydroxyurea: a preliminary report of the Registro Italiano Trombocitemia (RIT) 57
PEG Intron treatment in 90 patients with assential thrombocithemia (ET) final report of a phase II study 57
Blood hypercoagulability as a risk factor for leg ulcers in sickle cell disease. 57
Chronic idiopatic trombocytopenic purpura: is there any factor to predict the response to splenectomy? 57
Low-dose cytarabine in myelodisplastic syndromes and acute leukemia: a comment 56
All-Trans retinoic acid (ATRA) induced apoptosis in peripheral freshly iso- lated chronic myeloid leukemia cells. 56
Portal vein thrombosis after laparoscopic splenectomy: report on personal experience 56
Serum overexpresion of interleukin-15 in patients with essential thrombocythemia: which significance? 56
Acute lymphoblastic leukemia in elderly. 56
Increased thromboxane in patients with polycythemia vera and thrombosis: evidence for aspirin-unsuppressible platelet activation in vivo. 56
Antithrombin III concentrate for treatment of chronic leg ulcers in sickle cell-beta Thalassemia: a pilot study. 55
Effectiveness and safety of combined cytoreductive therapy in 56 patients with essential Thrombocythemia: report of the Regisro Italiano Trombocitemia (RIT) 55
COVID-19 in Essential Thrombocythemia: Coagulopathy and Thrombosis 55
Anagrelide treatment in 167 patients with essential thrombocythaemia : a retrospective study of the Italian Group GIMMC 55
Cardiovascular events and intensity of treatment in Polycythemia vera 55
The Antiphospholipid Syndrome 54
Autologous PBPC infusions may restore T-cells immunosuppression induced by fludarabine in NHL patients trated with fludamitoxantro- ne containing regimen. Preliminary experience. 54
JAK2V6176F mutation status and thrombosis in essential thrombocytemia 54
Totale 6.949
Categoria #
all - tutte 70.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.637


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.926 7 232 273 32 615 26 202 13 290 10 165 61
2021/20222.691 351 392 21 30 434 5 399 92 286 5 64 612
2022/20233.523 370 93 28 231 355 664 4 582 984 29 119 64
2023/20241.678 84 111 73 88 67 161 160 355 17 40 231 291
2024/20255.325 38 724 372 170 1.194 404 110 205 527 699 319 563
2025/2026100 100 0 0 0 0 0 0 0 0 0 0 0
Totale 17.943